X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INTERVIROLOGY

期刊標題檢索 INTERVIROLOGY 最新評論: Manuscript of the article (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INTERVIROLOGY]您好,您是該頁面的第 14919 位訪客。

期刊簡介
期刊名稱INTERVIROLOGY INTERVIROLOGY
LetPub Score
5.3
50 ratings
Rate

Reputation
6.3

Influence
3.6

Speed
9.1

期刊簡稱INTERVIROLOGY
ISSN0300-5526
E-ISSN1423-0100
h-index57
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.400.5560.674
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Infectious Diseases
Q2130 / 344
Category: Medicine
Subcategory: Virology
Q341 / 80

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
'Intervirology' covers progress in both basic and clinical virus research, and aims to provide a forum for the various disciplines within virology. Issues publishing original papers alternate with thematic issues, focusing on clearly defined topics. This thematic concentration serves to make timely reviews, research reports and controversy easily accessible to both specialists in the field and those who want to keep track of the latest developments outside their own area of interest. In addition to original papers, regular issues publish short communications and letters to the editor to provide readers with a forum for the exchange of ideas and comments. The scope encompasses work on the molecular biology of human and animal viruses, including genome organization and regulation, and the structure and function of viral proteins. The pathogenesis, immunology, diagnosis, epidemiology, prophylaxis and therapy of viral diseases are considered.
官方網站http://www.karger.com/Journal/Home/224031
在線稿件提交http://www.karger.com/Journal/Guidelines/224031
開放訪問No
出版商S. Karger AG
主題領域医学
出版國/地區SWITZERLAND
發行頻率隔月刊行
創刊年1973
每年文章數10每年文章數趨勢
黃金OA百分比100.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
VIROLOGYSCIEQ322/41
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0300-5526%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【INTERVIROLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    REVIEWS IN MEDICAL VIROLOGYH-index: 84

    CiteScore: 21.40
    JOURNAL OF MEDICAL VIROLOGYH-index: 105

    CiteScore: 23.20
    PLoS PathogensH-index: 174

    CiteScore: 11.40
    ANTIVIRAL RESEARCHH-index: 108

    CiteScore: 17.10
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGYH-index: 82

    CiteScore: 9.70
    Influenza and Other Respiratory VirusesH-index: 46

    CiteScore: 7.20
    JOURNAL OF CLINICAL VIROLOGYH-index: 97

    CiteScore: 22.70
    Journal of VirologyH-index: 271

    CiteScore: 10.10
    Virology JournalH-index: 70

    CiteScore: 7.40
    JOURNAL OF GENERAL VIROLOGYH-index: 152

    CiteScore: 7.70
    學科內最受檢索的期刊 頁面查看次數
    Journal of Virology178217
    PLoS Pathogens177833
    VIRUS RESEARCH128387
    JOURNAL OF MEDICAL VIROLOGY105809
    ANTIVIRAL RESEARCH84460
    VIROLOGY83738
    Virology Journal76973
    ARCHIVES OF VIROLOGY60833
    JOURNAL OF GENERAL VIROLOGY52937
    AIDS42295
  •  

    INTERVIROLOGY INTERVIROLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [INTERVIROLOGY] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:43:55 評論於
Manuscript of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:27:29 評論於
Currently ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researchers associated with their publications to use an ORCID iD.
If an article is published without providing an ORCID ID, how can it be added?
ORCID stands for Open Researcher and Contributor ID. The ORCID iD is a unique and persistent academic identifier for contributors, distinguishing authors from other researchers and recording all of the author's related research activities. Authors need to log into their individual accounts and then link them in the account information settings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 23:28:05 評論於
Is it necessary to provide the ORCID iDs of each author when submitting a manuscript?
(0) 讚! | 深渊兴业

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:14:28 評論於
What is MS?
(0) 讚! | Darlene Pepys

作者: Caesar Hart


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-05 08:44:52 評論於
How long does the first instance take???
(0) 讚! | Caesar Hart

作者: Caesar Hart


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-03 11:22:26 評論於
The manuscript submitted in August last year was marked as decision pending a few days ago, but now it has returned to in review. Any chances of acceptance? Should I continue waiting?
(0) 讚! | Caesar Hart

作者: 碧桃逸致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-08 08:47:27 評論於
Although there was only a little over a month, the quality of the manuscript is quite demanding. However, the review process is particularly slow, and after three months, it has not been sent for external review at all. The editor said that the quality of the manuscript was not high and rejected it. I really hope to be notified earlier
(0) 讚! | 碧桃逸致

作者: eriel


領域: 医学
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2018-09-08 01:54:51 評論於
A little more, but the quality of the manuscript is quite required.Only the review process was particularly slow. After three months passed, there was no external trial. The editor said that the quality of the manuscript was not high, and I really hope that I can inform you earlier.
(0) 讚! | eriel

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 18:32:05 評論於
It's a bit bleak, can't even hold on to this 1.5 marks, how to live?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-01-11 19:16:00 評論於
Review speed: 12.0 | Submission hit rate: 50.0
Experience sharing: It took 11 months from submission to acceptance, the review process was slow, the publication efficiency was low, and the English language requirements were not high
(0) 讚! | 凌霄高洁

作者: 云来乙涵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-09-23 08:16:55 評論於
Review speed: 1.0 | Submission hit rate: 25.0
Experience sharing: I submitted an article on August 23rd, and it was directly rejected without review on September 23rd. I feel that this journal is not very good. This article may not have been sent for review at all, but it was under review the whole time. Any comments were not directly rejected. It should be noted that this article is not too bad. I have previously submitted to a journal with an impact factor of 2.1 and it was majorly revised. I don't know why this journal is like this
(0) 讚! | 云来乙涵

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-01-25 22:26:02 評論於
The speed of peer review varies depending on who is reviewing the article. In our laboratory, we submitted 3 papers. The one I submitted took 7 months with multiple reminders before it was accepted. The other two were accepted in less than two months and in 2-3 months, respectively
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-04-21 18:44:28 評論於
The magazine is not as fast as mentioned upstairs. I have submitted mine two months ago and still haven't heard any news. I've even followed up twice but haven't received any feedback from the reviewers so far
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2009-12-15 10:32:36 評論於
Journal Name: Intervirology 
Field of Expertise: Virology 
Country of Journal: Switzerland 
Year of Submission: 2009 
Peer-review Time: 30-40 days 
Minor Revisions Required: Yes 
Time from Submission to Acceptance (or Rejection): Acceptance in 40 days 
Language Proofreading Required: No 
Page Charges: Free for up to 6 pages, 140CHF for each additional page 

Personal Comments (Feelings or Experience): The peer-review process is very fast. Our lab has published 4 articles in this journal, with the quickest acceptance being within 30 days. Of course, your article needs to be innovative. People in a rush to graduate can submit to this journal
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [INTERVIROLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*